[Treatment of gastroesophageal reflux disease].
Herszényi
László
L
Semmelweis Egyetem, Altalános Orvostudományi Kar, II. Belgyógyászati Klinika, Budapest. herlasz@freemail.hu
D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D015738:Famotidine / Q000627:therapeutic use; D005764:Gastroesophageal Reflux / Q000150:complications / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D008019:Life Style; D016567:Nizatidine / Q000627:therapeutic use; D011899:Ranitidine / Q000627:therapeutic use
D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D015738:Famotidine; D011899:Ranitidine; D016567:Nizatidine